- Išparduota
/https://libri-media.knygos-static.lt/7f41d88d-b1ce-47b2-87eb-c8f4bcb76cdb/1)
- Autorius: Sarfaraz K. Niazi
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2019
- Puslapiai: 592
- ISBN: 9781351594912
- ISBN-10: 1351594915
- ISBN-13: 9781351594912
- Formatas: ACSM ?
- Kalba: Anglų
Handbook of Pharmaceutical Manufacturing Formulations, Third Edition (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Formatai:
Aprašymas
The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent.
Elektroninė knyga:
Atsiuntimas po užsakymo akimirksniu! Skirta skaitymui tik kompiuteryje, planšetėje ar kitame elektroniniame įrenginyje.
Kaip skaityti el. knygas ACSM formatu?
Mažiausia kaina per 30 dienų: 102,39 €
Mažiausia kaina užfiksuota: Kaina nesikeitė
- Autorius: Sarfaraz K. Niazi
- Leidėjas: Taylor & Francis Ltd.
- Metai: 2019
- Puslapiai: 592
- ISBN: 9781351594912
- ISBN-10: 1351594915
- ISBN-13: 9781351594912
- Formatas: ACSM ?
- Kalba: Anglų
The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume One, Compressed Solid Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this first volume of a six-volume set, compiles data from FDA new drug applications, patent applications, and other sources of generic and proprietary formulations to cover the broad spectrum of GMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent.
Atsiliepimai